Is the Force Awakened? Publication Trends in Oncology Big Data as Phase II CancerLinQ is Launched

Background: The American Society of Clinical Oncology launched CancerLinQ project in 2010 to provide real-time data collection, mining and visualization, clinical decision support, and quality feedback. Creation of a big data software platform is currently underway to power the CancerLinQ in the phase II of the project. This would allow for evidence driven practice and rapid learning for cancer care providers. Additionally, adequate knowledge about the utility of Big Data to encourage provider utilization in high Impact Factor (IF) journals is needed. We aimed to assess trends and quality of Big Data published in Oncology. Methods: Peer-reviewed English papers published between 2011 and 2015 reporting on cancer and Big Data were identified using PubMed. Manual review was conducted. Cohort construction and statistical analyses were performed utilizing SPSS v 21.0 Results: We identified 325 publications, 135 met inclusion criteria in 105 journals, of which 36% (n=38) are considered specialized hematology and/or oncology journals. Specialized journals published 29.62% (40/135). Equal distribution of publications was found in clinical and basic science journals; 54 (37%) and 50 (40%) respectively. There was a trend of increased publications in clinical journals from 2012 to 2015 (16.7% to 42.9%, P = 0.39). Of the available Impact factors (IF) – the median is 3.234 (range 0.00-41.456) with 25/125 (20.0%) of available IF being \u3e 5.00 and 12/125 (9.6%) being \u3e 10.00 with no difference in the proportion of IF \u3e 5.00 in clinical versus basic science journals; 11/51 (21%) versus 11/47 (23) % p = 1.00, respectively. Conclusions: The need for further publication of studies addressing Big Data use in furthering oncology research is being met by the research community in response to the CancerLinQ as demonstrated by the rapid increase in publications. We hypothesize that this will increase the likelihood of cancer providers using CancerLinQ in the future, although an increase in publication in specialized journals and in those with high impact factors is still necessary. Currently, despite the increased trend of publications addressing Big Data in oncology, less than one-third of these publications are in specialized journals

Accidents exposing blood to the staff of a hospital and university establishment in Algeria: Assessment and risk factors

Background: Accidents exposing to blood AEB represent real public health problem in healthcare establishments. The objective of our study was to estimate the frequency of AEB As at our establishment as well as the risk factors that determine their occurrence. Patients and Methods: A cross-sectional descriptive survey was conducted at a hospital university establishment over period from October 16 to December 3, 2018. The survey concerned accident exposing blood to the staff of our establishment. Data entry and analysis was carried out using Epi-Info software. Results: A clear predominance of women was noted (79.2%) among the study population with a Sex ratio equal to 0.26. The average age was 27.7 ± 6.2 years.The frequency of exposure to AEB among hospital staff was 48.5%. Needlestick injuries were the most common accident (88.3%), followed by splashing blood or body fluids (51.7%), and cutting with a sharp object (10.0%). Among the risk factors significantly associated with the occurrence of AEB, we can cite the medical profession (OR = 3.94; p<0.001), the surgical specialty (OR = 3.3; p <0.01), the male sex (OR = 3.7; p <0.01). Likewise, risk of AEB increased significantly with age (p <0.01) and professional seniority (p <0.02). Keywords: Accidents exposing blood; hospital staff; Algeria

Investment efficiency of floating platforms desalination technology in Egypt

Over 2,000 km of sea coasts with different environmental conditions may provide Egypt with alternative energy solution that may be used for electricity production and water desalination, required for the vast urban expansion, mainly along the coastal areas to relieve population pressure from the old valley and delta, and to create new community opportunities in new regions. The proposed platform discussed in this paper is a mobile platform in order to supply any costal city with fresh water to prevent any water crisis. The aim of this research paper is to make an economic comparison between floating stations and fixed stations on the ground and to determine the extent of the preference of one over the other to take the appropriate investment decision that can benefit the vast Egyptian coasts. The result of the study showed the possibility of recovering the invested capital during a period of 5 years and 5 months for the floating platform and 5 years and 8 months for the fixed ground station. Economic indicators have also been used to conduct comparison such as net present value of cash flows, cost-to-cost standard, internal rate of return, sensitivity analysis ([10% cost increase] [10% decrease in revenue] [both together]). All results were positive in favour of the floating platform of the desalination plant

Asc-Dependent and Independent Mechanisms Contribute to Restriction of Legionella Pneumophila Infection in Murine Macrophages

The apoptosis-associated speck-like protein containing a caspase recruitment domain (Asc) is an adaptor molecule that mediates inflammatory and apoptotic signals. Legionella pneumophila is an intracellular bacterium and the causative agent of Legionnaire's pneumonia. L. pneumophila is able to cause pneumonia in immuno-compromised humans but not in most inbred mice. Murine macrophages that lack the ability to activate caspase-1, such as caspase-1−/− and Nlrc4−/− allow L. pneumophila infection. This permissiveness is attributed mainly to the lack of active caspase-1 and the absence of its down stream substrates such as caspase-7. However, the role of Asc in control of L. pneumophila infection in mice is unclear. Here we show that caspase-1 is moderately activated in Asc−/− macrophages and that this limited activation is required and sufficient to restrict L. pneumophila growth. Moreover, Asc-independent activation of caspase-1 requires bacterial flagellin and is mainly detected in cellular extracts but not in culture supernatants. We also demonstrate that the depletion of Asc from permissive macrophages enhances bacterial growth by promoting L. pneumophila-mediated activation of the NF-κB pathway and decreasing caspase-3 activation. Taken together, our data demonstrate that L. pneumophila infection in murine macrophages is controlled by several mechanisms: Asc-independent activation of caspase-1 and Asc-dependent regulation of NF-κB and caspase-3 activation

Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study

Summary Background Congenital anomalies are the fifth leading cause of mortality in children younger than 5 years globally. Many gastrointestinal congenital anomalies are fatal without timely access to neonatal surgical care, but few studies have been done on these conditions in low-income and middle-income countries (LMICs). We compared outcomes of the seven most common gastrointestinal congenital anomalies in low-income, middle-income, and high-income countries globally, and identified factors associated with mortality. Methods We did a multicentre, international prospective cohort study of patients younger than 16 years, presenting to hospital for the first time with oesophageal atresia, congenital diaphragmatic hernia, intestinal atresia, gastroschisis, exomphalos, anorectal malformation, and Hirschsprung’s disease. Recruitment was of consecutive patients for a minimum of 1 month between October, 2018, and April, 2019. We collected data on patient demographics, clinical status, interventions, and outcomes using the REDCap platform. Patients were followed up for 30 days after primary intervention, or 30 days after admission if they did not receive an intervention. The primary outcome was all-cause, in-hospital mortality for all conditions combined and each condition individually, stratified by country income status. We did a complete case analysis. Findings We included 3849 patients with 3975 study conditions (560 with oesophageal atresia, 448 with congenital diaphragmatic hernia, 681 with intestinal atresia, 453 with gastroschisis, 325 with exomphalos, 991 with anorectal malformation, and 517 with Hirschsprung’s disease) from 264 hospitals (89 in high-income countries, 166 in middleincome countries, and nine in low-income countries) in 74 countries. Of the 3849 patients, 2231 (58·0%) were male. Median gestational age at birth was 38 weeks (IQR 36–39) and median bodyweight at presentation was 2·8 kg (2·3–3·3). Mortality among all patients was 37 (39·8%) of 93 in low-income countries, 583 (20·4%) of 2860 in middle-income countries, and 50 (5·6%) of 896 in high-income countries (p<0·0001 between all country income groups). Gastroschisis had the greatest difference in mortality between country income strata (nine [90·0%] of ten in lowincome countries, 97 [31·9%] of 304 in middle-income countries, and two [1·4%] of 139 in high-income countries; p≤0·0001 between all country income groups). Factors significantly associated with higher mortality for all patients combined included country income status (low-income vs high-income countries, risk ratio 2·78 [95% CI 1·88–4·11], p<0·0001; middle-income vs high-income countries, 2·11 [1·59–2·79], p<0·0001), sepsis at presentation (1·20 [1·04–1·40], p=0·016), higher American Society of Anesthesiologists (ASA) score at primary intervention (ASA 4–5 vs ASA 1–2, 1·82 [1·40–2·35], p<0·0001; ASA 3 vs ASA 1–2, 1·58, [1·30–1·92], p<0·0001]), surgical safety checklist not used (1·39 [1·02–1·90], p=0·035), and ventilation or parenteral nutrition unavailable when needed (ventilation 1·96, [1·41–2·71], p=0·0001; parenteral nutrition 1·35, [1·05–1·74], p=0·018). Administration of parenteral nutrition (0·61, [0·47–0·79], p=0·0002) and use of a peripherally inserted central catheter (0·65 [0·50–0·86], p=0·0024) or percutaneous central line (0·69 [0·48–1·00], p=0·049) were associated with lower mortality. Interpretation Unacceptable differences in mortality exist for gastrointestinal congenital anomalies between lowincome, middle-income, and high-income countries. Improving access to quality neonatal surgical care in LMICs will be vital to achieve Sustainable Development Goal 3.2 of ending preventable deaths in neonates and children younger than 5 years by 2030

The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance

INTRODUCTION Investment in Africa over the past year with regard to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing has led to a massive increase in the number of sequences, which, to date, exceeds 100,000 sequences generated to track the pandemic on the continent. These sequences have profoundly affected how public health officials in Africa have navigated the COVID-19 pandemic. RATIONALE We demonstrate how the first 100,000 SARS-CoV-2 sequences from Africa have helped monitor the epidemic on the continent, how genomic surveillance expanded over the course of the pandemic, and how we adapted our sequencing methods to deal with an evolving virus. Finally, we also examine how viral lineages have spread across the continent in a phylogeographic framework to gain insights into the underlying temporal and spatial transmission dynamics for several variants of concern (VOCs). RESULTS Our results indicate that the number of countries in Africa that can sequence the virus within their own borders is growing and that this is coupled with a shorter turnaround time from the time of sampling to sequence submission. Ongoing evolution necessitated the continual updating of primer sets, and, as a result, eight primer sets were designed in tandem with viral evolution and used to ensure effective sequencing of the virus. The pandemic unfolded through multiple waves of infection that were each driven by distinct genetic lineages, with B.1-like ancestral strains associated with the first pandemic wave of infections in 2020. Successive waves on the continent were fueled by different VOCs, with Alpha and Beta cocirculating in distinct spatial patterns during the second wave and Delta and Omicron affecting the whole continent during the third and fourth waves, respectively. Phylogeographic reconstruction points toward distinct differences in viral importation and exportation patterns associated with the Alpha, Beta, Delta, and Omicron variants and subvariants, when considering both Africa versus the rest of the world and viral dissemination within the continent. Our epidemiological and phylogenetic inferences therefore underscore the heterogeneous nature of the pandemic on the continent and highlight key insights and challenges, for instance, recognizing the limitations of low testing proportions. We also highlight the early warning capacity that genomic surveillance in Africa has had for the rest of the world with the detection of new lineages and variants, the most recent being the characterization of various Omicron subvariants. CONCLUSION Sustained investment for diagnostics and genomic surveillance in Africa is needed as the virus continues to evolve. This is important not only to help combat SARS-CoV-2 on the continent but also because it can be used as a platform to help address the many emerging and reemerging infectious disease threats in Africa. In particular, capacity building for local sequencing within countries or within the continent should be prioritized because this is generally associated with shorter turnaround times, providing the most benefit to local public health authorities tasked with pandemic response and mitigation and allowing for the fastest reaction to localized outbreaks. These investments are crucial for pandemic preparedness and response and will serve the health of the continent well into the 21st century

Autoimmune hemolytic anemia in cancer disorders

© 2016 Nova Science Publishers, Inc. Autoimmune hemolytic anemia (AIHA) results from auto-antibody mediated, uncompensated consumption of red blood corpuscle. AIHA is either idiopathic (primary) or secondary to other disorders. Secondary AIHA in cancer patients is drug induced or cancer cell induced, or may occur as part of paraneoplastic syndrome. AIHA phenomenon has been described in patients with hematological malignancies. In patients with chronic lymphocytic leukemia, and patients with Waldenstrom macroglobulinemia, an incidence of 5-15% and 10-20%, respectively, is noted. AIHA has been reported to a lesser extent with other malignant lymphomas, B-cell lymphocytic leukemia, and multiple myeloma. AIHA is much rarer with solid tumors such as ovarian malignancies, renal neoplasms, and Kaposi sarcoma. Furthermore, drug-induced AIHA has been reported with certain chemotherapeutic agents such as oxaliplatin. Cancer-associated AIHA is mostly direct Coombs’ positive, and to a lesser extent, cancer-associated AIHA can be either positive for both direct and indirect Coombs’ tests, or Coombs’ negative. Coombs’ positivity is associated with wide variability of the type of antibodies/hemolytic factors. The underlying mechanisms for the AIHA are correlated to either the paraneoplastic disorder or immune dysregulation. Although treatment of cancer-associated AIHA depends upon the associated malignancy, all treatments focus on better control of the underlying malignancy. Some treatments include steroids, rituximab, or cyclosporine

Modelling of coal-biomass blends gasification and power plant revamp alternatives in Egypt's natural gas sector

Recently, there has been a growing research interest in the co-gasification of biomass with coal to produce syngas and electricity in a sustainable manner. Co-gasification technology do not only decrease potentially the exploitation of a significant amount of conventional coal resources, and thus lower greenhouse gases (GHG) emissions, but also boost the overall gasification process efficiency. In the present work, a rigorous simulation model of an entrained flow gasifier is developed using the Aspen Plus® software environment. The proposed simulation model is tested for an American coal and the model validation is performed in good agreement with practical data. The feedstocks used in the proposed gasifier model are dry Egyptian coal and a blend of an Egyptian coal and rice straw that is gathered locally. The proposed gasifier model mainly consists of three reactors. The first one is a yield reactor where the coal pyrolysis occurs, the second reactor is a stoichiometric reactor where the gasification reactions arise, and the third reactor is a Gibbs reactor where the water-gas and steam-methane reforming reactions take place. The influence of using a feed mixture of 90 % coal and 10 % rice straw on the gasifier efficiency is investigated. The developed model provides a robust basis for revamping of an existing Egyptian natural gas-based power plant to replace its standard fuel with a coal-rice straw blend, in case of low natural gas supply. The model is further employed to assess different revamping scenarios and alternatives within the natural gas power plant. For a dry blend of (90 % Egyptian coal and 10 % rice straw), the cold gas efficiency is estimated as 85.7 %, while for dry Egyptian it is calculated as 79.61 %. The revamped Egyptian natural gas power plant decreases the total annualized cost (TAC) by 52.7 % with respect to a new constructed integrated gasification combined cycle (IGCC) plant. Besides, the payback period decreases to 1.24 y rather than 12 y in case of the construction of a new IGCC power plant